Skip to main content

Featured

Canada’s Auto Industry Is Split on a U.S. Tariff Deal: What It Means for Your Wallet

  Canadian Money Brief • Tariffs & Trade • Saturday, November 14, 2026 Ottawa is once again trying to land a tariff deal with Washington. This time, the biggest fight may be inside Canada's own auto industry, and the outcome could reach your paycheque, your car purchase and your savings. Canada's auto manufacturers agree on the goal: get U.S. tariffs on Canadian-built vehicles down. They do not agree on how fast to move or what to accept. According to a Globe and Mail report published overnight, the Detroit Three (Ford, GM and Stellantis) want a deal sooner rather than later, even an imperfect one, while Honda and Toyota are pushing Ottawa toward a very different design. It matters now because of the clock. Canadian-built vehicles already face a 25% U.S. tariff on their non-American content, and Washington has threatened to double the headline rate to 50% on January 1, 2027. Honda has warned that doubling would be catastrophic for the North American industry. Prime Minister...

article

Provincial Directive Curbs AHS Authority Over Private Surgical Contract Negotiations

 


In a significant policy shift, Alberta Health Minister Adriana LaGrange has stripped Alberta Health Services (AHS) of its authority to negotiate contracts with private surgical facilities. According to a government directive obtained by media, the change came after internal concerns—raised by the agency’s then-chief executive—over rising contract costs.

Documents, including a letter from former AHS CEO Athana Mentzelopoulos’s lawyer, allege that senior government officials—even involving Premier Danielle Smith’s former chief of staff—intervened in AHS’s procurement process to favor private companies. This interference reportedly undermined AHS’s established negotiation powers and raised serious questions about transparency in the province’s health system. 

A separate report in a Morning Update from Unpublished Newswire reiterated the move, noting that the directive is part of broader reforms aimed at reducing costs by leveraging competitive pricing in surgical services.  Meanwhile, a CityNews investigation has added context to the controversy, citing denials by private surgical providers who label the allegations of sweetheart deals as “false and baseless.” 

Critics and opposition leaders are calling for further inquiry into the decision-making process behind these changes, arguing that the shift could signal a move toward greater privatization of public health services. In contrast, government representatives insist that the directive is intended solely to improve efficiency and ensure more competitive pricing for publicly funded operations.

Comments